Nyamyc recalled over manufacturing violations
- Recall date
- January 26, 2022
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- CARDINAL HEALTHCARE recalls Nyamyc, 100,000 USP units per gram, 60 grams, Rx only, Topical Use Only, Manufactured by: Upsher-Smith Laboratories, In…
- Recall number
- D-0192-2024
- FDA classification
- Class II
- Brand / firm
- CARDINAL HEALTHCARE
- Sold / distributed
- Nationwide USA
Why it was recalled
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Nyamyc, 100,000 USP units per gram, 60 grams, Rx only, Topical Use Only, Manufactured by: Upsher-Smith Laboratories, Inc, Minneapolis, MN 55447.
Get recall alerts
Free email alert whenever CARDINAL HEALTHCARE has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: CARDINAL HEALTHCARE